Evidence map›Paper›PMID 39699191›Full record

ArticlemSphere2025

Development of monoclonal antibodies against

Mingya Cao, Siyu Wang, Shengke Zhou, Min Yan, Yu Zou, Yuan Cui, Xinyu Lou, Yichang Gao, Ying Chen, Zijing Han and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Virulence diversity amongJournal of oral microbiology · 2026
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mingya Cao *Joint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.ORCID 0009-0008-9911-3991
Siyu Wang *Joint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Shengke Zhou *Joint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Min YanJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Yu ZouJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Yuan CuiJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Xinyu LouJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Yichang GaoJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Ying ChenJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Zijing HanJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.
Yi QianThe First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.
Jingying ChenJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.ORCID 0000-0002-3159-1101
Xia LiJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, China.ORCID 0000-0001-7875-6527

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IMPORTANCE: Fimbriae (pili) play an important role in bacterial adhesion, invasion of host cells and tissues, and formation of biofilms. Studies have shown that two types of fimbriae of

Indexed as

Antibodies, BacterialAntibodies, MonoclonalFimbriae ProteinsPeriodontitisPorphyromonas gingivalisAlveolar Bone LossAnimalsBacterial AdhesionBacterial ProteinsBacteroidaceae InfectionsDisease Models, AnimalFemaleHumansMiceMice, Inbred BALB CAntibodies, BacterialAntibodies, MonoclonalBacterial ProteinsFimbriae ProteinsMfa1 protein, Porphyromonas gingivalisfimbriaeMfa1monoclonal antibodiesperiodontitisP. gingivalis

Identifiers

PMID39699191
PMCPMC11774036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.